Vitamin C and Cordyceps for quality of life in advanced pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests whether a combination of high-dose vitamin C and cordyceps (a type of fungus used in traditional medicine) can improve quality of life for people with late-stage pancreatic cancer that has progressed after two prior treatments. It looks at how these supplements affect your well-being and daily living.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with pancreatic cancer that has spread to other parts of the body and has gotten worse after two previous treatments.
- You are able to care for yourself and are up and about at least half of the day (ECOG score 0-2).
- Your organs (like liver, kidneys, bone marrow) are working well enough based on blood tests.
- You have at least one tumor that can be measured on scans.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you are willing to use effective birth control during the study.
- You do not have a G6PD deficiency (a genetic condition that can affect how your body handles certain drugs).
- You do not have active inflammation in your digestive tract, such as pancreatitis or cholangitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding vitamin C and a fungus called cordyceps to standard chemotherapy can help improve anemia (low red blood cells) in people with advanced pancreatic cancer. It's for those who have not yet had treatment for their cancer.
This trial tests whether a special nutrition program can help people with pancreatic cancer who are getting chemotherapy before surgery. The program includes diet changes, supplements, and exercise support to see if it improves strength, weight, and overall well-being.
This trial tests a new treatment that combines a cancer-killing virus with an immunotherapy drug (a PD-1 inhibitor) for advanced pancreatic cancer. It aims to see if this combination can help shrink tumors and improve outcomes for patients who have already tried chemotherapy.
This trial looks at whether personalised nutritional care can help older patients with pancreatic cancer feel better and cope with treatment. You will receive a nutrition plan tailored to your needs, and the study will follow how this affects your health and treatment experience.
This trial tests whether adding astragalus, an herbal supplement, to the standard chemotherapy drug gemcitabine before surgery can improve outcomes for people with pancreatic cancer. It is a phase 2 study designed to see if the combination is safe and effective.
This trial tests a new immunotherapy drug called ivonescimab combined with chemotherapy, with or without another experimental drug (AK117), for people with pancreatic cancer that has spread. The goal is to see if adding these therapies can help shrink tumors or slow the cancer's growth.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.